Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the United States: Insights from the REACH registry

Critical Pathways in Cardiology

Volumn 8, Issue 2, 2009, Pages 91-97

  Eagle, Kim A ^a   Hirsch, Alan T ^b   Califf, Robert M ^c   Alberts, Mark J ^d   Steg, P Gabriel ^e   Cannon, Christopher P ^f   Brennan, Danielle M ^g   Bhatt, Deepak L ^h  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e INSERM   (France)

^f HARVARD MEDICAL SCHOOL   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerotic risk; Atherothrombosis; Cerebrovascular disease; Coronary artery disease; Peripheral arterial disease

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; NITRATE;

ADULT; AGED; ARTICLE; ATHEROTHROMBOSIS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; UNITED STATES;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; UNITED STATES;

EID: 68049097214     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e3181a84613     Document Type: Article

References (31)

1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
2. Drouet L. Atherothrombosis as a systemic disease. Cerebrovasc Dis. 2002;13(suppl 1):1-6.
3. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-e181.
4. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
5. Newman AB, Shemanski L, Manolio TA, et al; the Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538-545.
6. Vliegenthart R, Hollander M, Breteler MM, et al. Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke. 2002;33:462-465.
7. Cotter G, Cannon CP, McCabe CH, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003;145:622-627.
8. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-189.
9. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515.
10. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324.
11. Vogt MT, Cauley JA, Newman AB, et al. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA. 1993;270:465-469.
12. Marinelli MR, Beach KW, Glass MJ, et al. Noninvasive testing vs clinical evaluation of arterial disease: a prospective study. JAMA. 1979;241:2031-2034.
13. Smith SC Jr, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation. 2000;101:111-116.
14. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
15. The West of Scotland Coronary Prevention Study Group. Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. Am J Cardiol. 1997;79:756-762.
16. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197-1206.
17. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163-194.
18. Butler D. Health experts find obesity measures too lightweight. Nature. 2004;428:244.
19. Bonow RO, Eckel RH. Diet, obesity, and cardiovascular risk. N Engl J Med. 2003;348:2057-2058.
20. Lee CD, Folsom AR, Pankow JS, et al. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855-860.
21. Luepker RV, Rastam L, Hannan PJ, et al. Community education for cardiovascular disease prevention. Morbidity and mortality results from the Minnesota Heart Health Program. Am J Epidemiol. 1996;144:351-362.
22. Mahonen M, Tolonen H, Kuulasmaa K. MONICA Coronary Event Registration Data Book 1980-1995. Available at: http://www.ktl.fi/publications/monica/coredb/ coredb.htm. Accessed August 20, 2007.
23. Sytkowski PA, D'Agostino RB, Belanger A, et al. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol. 1996;143:338-350.
24. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
25. Duvall WL, Vorchheimer DA. Multi-bed vascular disease and atherothrombosis: scope of the problem. J Thromb Thrombolysis. 2004;17:51-61.
26. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481-1501.
27. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-654.
28. Belch JJ, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163:884-892.
29. Diehm C, Kareem S, Lawall H. Epidemiology of peripheral arterial disease. VASA. 2004;33:183-189.
30. Selvin E, Hirsch AT. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis. 2008;201:425-433.
31. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Vital Health Stat 10. 2007;235:1-153.